| human | Q5 |
| P108 | employer | Hannover Medical School | Q911561 |
| P735 | given name | Peter | Q2793400 |
| Peter | Q2793400 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
| Q61848920 | 328: The timing of amniotomy, oxytocin and epidural and its association to labor duration and mode of birth |
| Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
| Q91967950 | A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms |
| Q33747778 | A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. |
| Q29417084 | A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. |
| Q59237589 | A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer |
| Q38281649 | A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2. |
| Q64984244 | A randomized trial comparing limited-excision conisation to Large Loop Excision of the Transformation Zone (LLETZ) in cervical dysplasia patients. |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q39349070 | A tumor-derived population (SCCOHT-1) as cellular model for a small cell ovarian carcinoma of the hypercalcemic type |
| Q35168741 | Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study |
| Q38406780 | Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study |
| Q52647897 | Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. |
| Q51920995 | Advanced first trimester screening (AFS): an improved test strategy for the individual risk assessment of fetal aneuploidies and malformations. |
| Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
| Q42371458 | Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci |
| Q39198367 | Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe |
| Q45797154 | Aneuploidy screening during pregnancy by a three-dimensional Advanced First Trimester Screening model: description of the AFS-3D algorithm |
| Q44712404 | Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy |
| Q51920999 | Are nuchal translucency, pregnancy associated plasma protein-A or free-beta-human chorionic gonadotropin depending on maternal age? A multicenter study of 8,116 pregnancies. |
| Q40012424 | Aromatase inhibitors as solely treatment in postmenopausal breast cancer patients. |
| Q30276986 | Assessing the genetic architecture of epithelial ovarian cancer histological subtypes |
| Q40381692 | Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer |
| Q37684409 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q47420142 | Association between intraabdominal pressure during gynaecologic laparoscopy and postoperative pain |
| Q95935919 | Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study |
| Q51796714 | Association between women's self-diagnosis of labor and labor duration after admission. |
| Q96680596 | Association of genomic variants at the Human Leukocyte Antigen locus with cervical cancer risk, HPV status, and gene expression |
| Q39423088 | Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q74664460 | Autofluorescence spectroscopy for the diagnosis of cervical intraepithelial neoplasia |
| Q35940177 | Axillary dissection in primary breast cancer: variations of the surgical technique and influence on morbidity |
| Q38089412 | Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group |
| Q34327945 | Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 |
| Q36419325 | CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer |
| Q28385765 | Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk |
| Q64275471 | Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer |
| Q35782435 | Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer |
| Q41681181 | Clinical diagnosis and therapy of uterine scar defects after caesarean section in non-pregnant women |
| Q35732867 | Clinical presentation, treatment and outcome of vaginal intraepithelial neoplasia |
| Q58735565 | Comment on the LACC Trial Investigating Early-stage Cervical Cancer by the Uterus Commission of the Study Group for Gynecologic Oncology (AGO) and the Study Group for Gynecologic Endoscopy (AGE) of the German Society for Gynecology and Obstetrics (DG |
| Q35668946 | Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk |
| Q36490507 | Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). |
| Q29417145 | Common variants at 19p13 are associated with susceptibility to ovarian cancer |
| Q36255665 | Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer |
| Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q51921248 | Comparison of Nicolaides' risk evaluation for Down's syndrome with a novel software: an analysis of 1,463 cases. |
| Q85085151 | Comparison of measured concentration values of biochemical serum markers with two immunoassay systems in first trimester screening for fetal aneuploidy |
| Q36026731 | Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer |
| Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
| Q34342248 | Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk |
| Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q52849294 | Corrigendum to "Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie AGO Study Group" [Eur J Cancer 49 (2013) 1905-1914]. |
| Q101216461 | Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers |
| Q34540224 | Dermoglandular rotation flaps for breast-conserving therapy: aesthetic results, patient satisfaction, and morbidity in comparison to standard segmentectomy |
| Q42248573 | Detection of E6-AP as a potential therapeutic target in cervical specimen of HPV-infected women |
| Q33728867 | Effects of photodynamic therapy using topical applied hexylaminolevulinate and methylaminolevulinate upon the integrity of cervical epithelium |
| Q31160231 | Efficacy and safety of hexaminolevulinate photodynamic therapy in patients with low-grade cervical intraepithelial neoplasia |
| Q50903696 | Enzyme-linked immunosorbent assay for p16(INK4a) - a new triage test for the detection of cervical intraepithelial neoplasia? |
| Q30245480 | Epidemiology and Early Detection of Cervical Cancer |
| Q24633316 | Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer |
| Q79746675 | Episiotomy and perineal tears presumed to be imminent: randomized controlled trial |
| Q81156301 | Episiotomy and perineal tears presumed to be imminent: the influence on the urethral pressure profile, analmanometric and other pelvic floor findings--follow-up study of a randomized controlled trial |
| Q36487146 | Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk |
| Q57319395 | Erratum: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer |
| Q33339733 | Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study. |
| Q36966218 | Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study |
| Q44525897 | Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples |
| Q44728096 | Evaluation of active camera control systems in gynecological surgery: construction, handling, comfort, surgeries and results |
| Q28272759 | Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy |
| Q53775479 | Evaluation of prognostic factors following flow-cytometric DNA analysis after cytokeratin labelling: I. Breast cancer. |
| Q54893226 | Evaluation of prognostic factors following flow-cytometric DNA analysis after cytokeratin labelling: II. Cervical and endometrial cancer. |
| Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
| Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
| Q35063160 | Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk |
| Q37002930 | Five endometrial cancer risk loci identified through genome-wide association analysis |
| Q44691723 | Fluorescence diagnosis with 5-ALA thermogel of cervical intraepithelial neoplasia |
| Q58735550 | Foetal Morbidity Depending on the Day and Time of Delivery |
| Q33859206 | Functional deficiency of NBN, the Nijmegen breakage syndrome protein, in a p.R215W mutant breast cancer cell line |
| Q36956156 | GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer |
| Q37389405 | Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer |
| Q98776366 | Genetic Susceptibility to Endometrial Cancer: Risk Factors and Clinical Management |
| Q54940815 | Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. |
| Q36218993 | Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium |
| Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
| Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q33778612 | Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. |
| Q96432094 | Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk |
| Q36276527 | Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer |
| Q36916243 | Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer |
| Q40053289 | Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene |
| Q47805889 | Gestational diabetes mellitus: an evaluation of gynecologists' knowledge of guidelines and counseling behavior |
| Q51313366 | Groin Recurrences in Node Negative Vulvar Cancer Patients After Sole Sentinel Lymph Node Dissection. |
| Q62583321 | Guideline adherence and clinical outcome in vulnerable and healthy breast cancer patients: Results of a prospective cross-sectional study in Germany |
| Q54559106 | HPV16-E6 mRNA is superior to cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumour cells in sentinel lymph nodes of patients with cervical cancer by quantitative reverse-transcription PCR. |
| Q33330850 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
| Q30252952 | History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium |
| Q38619748 | History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report |
| Q37006170 | Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. |
| Q30252854 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer |
| Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
| Q57170142 | Identification of nine new susceptibility loci for endometrial cancer |
| Q35541663 | Identification of six new susceptibility loci for invasive epithelial ovarian cancer |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q38637857 | Improved killing of ovarian cancer stem cells by combining a novel CAR-based immunotherapy and chemotherapy |
| Q51873057 | Improved prenatal aneuploidy screening using the novel advanced first-trimester screening algorithm: a multicenter study of 10,017 pregnancies. |
| Q34598957 | In vitro and in vivo therapeutic approach for a small cell carcinoma of the ovary hypercalcaemic type using a SCCOHT-1 cellular model |
| Q40348998 | Integration of HPV-16 and HPV-18 DNA in vulvar intraepithelial neoplasia |
| Q38980819 | Interference of Ca²⁺ with the proliferation of SCCOHT-1 and ovarian adenocarcinoma cells |
| Q45329184 | Interinstitutional variations in mode of birth after a previous caesarean section: a cross-sectional study in six German hospitals |
| Q45729327 | Is there a place for sentinel technique in treatment of vaginal cancer?: feasibility, clinical experience, and results |
| Q99556951 | LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trial |
| Q47953421 | Late radiation side effects, cosmetic outcomes and pain in breast cancer patients after breast-conserving surgery and three-dimensional conformal radiotherapy : Risk-modifying factors |
| Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
| Q33268640 | Lymph node metastasis detection of ovarian cancer by porphyrin fluorescence photodetection: case report |
| Q91555616 | Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study |
| Q91315351 | Maternal Overweight, Inflammation and Neurological Consequences for the Preterm Child: Results of the ELGAN Study |
| Q37709543 | Maternal anxiety and its correlation with pain experience during chorion villus sampling and amniocentesis |
| Q98772941 | Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer |
| Q36333368 | Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q77365912 | Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells |
| Q34460831 | Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer |
| Q37499453 | Mutation analysis of the ERCC4/FANCQ gene in hereditary breast cancer |
| Q51431905 | Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer. |
| Q114032161 | NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44 |
| Q47327554 | Neonatal and Maternal Short-Term Outcome Parameters in Instrument-Assisted Vaginal Delivery Compared to Second Stage Cesarean Section in Labour: A Retrospective 11-Year Analysis |
| Q26799669 | Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk |
| Q37356243 | Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. |
| Q43773075 | Nijmegen Breakage Syndrome mutations and risk of breast cancer |
| Q47847793 | Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom's syndrome, is associated with breast cancer in Slavic populations |
| Q48406476 | Onset of labour: women's experiences and midwives' assessments in relation to first stage duration |
| Q83134576 | Optimizing breast cancer follow-up: diagnostic value and costs of additional routine breast ultrasound |
| Q39146622 | Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study |
| Q37353838 | PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations |
| Q104135164 | Pelvic Lymphadenectomy in Vulvar Cancer - Does it make sense? |
| Q54258468 | Peri- and postoperative management and outcomes of morbidly obese patients (BMI > 40 kg/m2) with gynaecological disease. |
| Q39827879 | Pharmacokinetics and selectivity of porphyrin synthesis after topical application of hexaminolevulinate in patients with cervical intraepithelial neoplasia |
| Q37357226 | Photodynamic diagnosis and therapy in gynecology |
| Q36196629 | Photodynamic diagnosis with 5-aminolevulinic acid for intraoperative detection of peritoneal metastases of ovarian cancer: A feasibility and dose finding study |
| Q37709666 | Photodynamic therapy for intraepithelial neoplasia of the lower genital tract |
| Q34302064 | Photodynamic therapy of cervical intraepithelial neoplasia 1-3 and human papilloma virus (HMV) infection with methylaminolevulinate and hexaminolevulinate--a double-blind, dose-finding study |
| Q33379392 | Photodynamic therapy of cervical intraepithelial neoplasia with hexaminolevulinate |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q47583184 | Postoperative anatomic and quality-of-life outcomes after vaginal sacrocolporectopexy for vaginal vault prolapse |
| Q92031995 | Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 study |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q92944156 | Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study |
| Q73774030 | Pregnancy complications, obstetric risks, and neonatal outcome in singleton and twin pregnancies after GIFT and IVF |
| Q82668590 | Preimplantation genetic diagnosis (polar body biopsy) and trisomy 21 |
| Q82194757 | Prenatal diagnosis of an epignathus associated with a 49,XXXXY karyotype--a case report |
| Q44242400 | Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe |
| Q51116126 | Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe. |
| Q36356150 | Prognostic value of HPV-mRNA in sentinel lymph nodes of cervical cancer patients with pN0-status |
| Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
| Q83115905 | Quality assured ultrasound simulator training for the detection of fetal malformations |
| Q39922865 | Quality of life and satisfaction after breast cancer operation |
| Q43147832 | Quantitative enzyme-linked immunosorbent assay determination of an abundant hemoglobin-derived anti-infective peptide in human placenta |
| Q53769937 | Radical vaginal trachelectomy (RVT) combined with laparoscopic pelvic lymphadenectomy: prospective multicenter study of 100 patients with early cervical cancer. |
| Q39183862 | Radiofrequency endometrial ablation for the treatment of heavy menstrual bleeding among women at high surgical risk |
| Q40728414 | Rare ATAD5 missense variants in breast and ovarian cancer patients |
| Q30459293 | Real-time ultrasound elastography in 180 axillary lymph nodes: elasticity distribution in healthy lymph nodes and prediction of breast cancer metastases |
| Q92625144 | Recommendations Related to Genetic Testing for Breast Cancer |
| Q30276610 | Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium |
| Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
| Q97521462 | Reproductive capacity and recurrence of disease after surgery for moderate and severe endometriosis - a retrospective single center analysis |
| Q37300024 | Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. |
| Q40478226 | Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study. |
| Q38740698 | SCCOHT tumors acquire chemoresistance and protection by interacting mesenchymal stroma/stem cells within the tumor microenvironment |
| Q92537829 | SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study |
| Q47373907 | Sarcoma Risk in Uterine Surgery in a Tertiary University Hospital in Germany |
| Q39153037 | Sensitization of immune cells following hexylaminolevulinate photodynamic therapy of cervical intraepithelial neoplasia |
| Q50180176 | Sentinel Lymphadenectomy in Vulvar Cancer Using Near-Infrared Fluorescence From Indocyanine Green Compared With Technetium 99m Nanocolloid. |
| Q36089391 | Shared genetics underlying epidemiological association between endometriosis and ovarian cancer |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q64004349 | Shared heritability and functional enrichment across six solid cancers |
| Q82741258 | Sonographic monitoring of systemic and local methotrexate (MTX) therapy in patients with intact interstitial pregnancies |
| Q98577610 | Statement of the AGO and AG-CPC on the Aftercare/Follow-up for Surgical Procedures of the Lower Genital Tract after the Introduction of a New Cancer Screening Guideline |
| Q51736689 | Study of protoporphyrin IX (PpIX) pharmacokinetics after topical application of 5-aminolevulinic acid in urethral condylomata acuminata. |
| Q34408038 | TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study |
| Q35565362 | The Automated Breast Volume Scanner (ABVS): initial experiences in lesion detection compared with conventional handheld B-mode ultrasound: a pilot study of 50 cases |
| Q39192995 | The Benefit of Baseline Staging-Risk Assessment of Distant Breast Cancer Metastases by Tumor Stage |
| Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
| Q27853172 | The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients. |
| Q51512990 | The First Description of Docetaxel-Induced Recall Inflammatory Skin Reaction After Previous Drug Extravasation. |
| Q50776970 | The German cervical cancer screening model: development and validation of a decision-analytic model for cervical cancer screening in Germany. |
| Q38606461 | The Value of Partial HPV Genotyping After Conization of Cervical Dysplasias |
| Q83681048 | The cost efficiency of HPV vaccines is significantly underestimated due to omission of conisation-associated prematurity with neonatal mortality and morbidity |
| Q38499997 | The influence of lunar cycle on frequency of birth, birth complications, neonatal outcome and the gender: a retrospective analysis |
| Q84986046 | The risk of ectopic pregnancy following tubal reconstructive microsurgery and assisted reproductive technology procedures |
| Q79745611 | The significance of intracardiac Doppler sonography in terms of fetal growth retardation |
| Q46340167 | The significance of uterine notching in Doppler sonography in early pregnancy as a predictor for pathologic outcome of the pregnancy |
| Q31040267 | Treatment of high grade cervical intraepithelial neoplasia by photodynamic therapy using hexylaminolevulinate may be costeffective compared to conisation procedures due to decreased pregnancy-related morbidity |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
| Q30455601 | Ultrasound real-time elastography can predict malignancy in BI-RADS®-US 3 lesions |
| Q37740234 | Ultrasound versus Clinical Examination to Estimate Fetal Weight at Term |
| Q61795802 | Updated Opinion of the Uterus Commission of the Gynecological Oncology Working Group (AGO) and the Gynecological Endoscopy Working Group (AGE) of the German Society of Gynecology and Obstetrics (DGGG) on the Randomized Study Comparing Minimally Invas |
| Q74550013 | Uterine dehiscence in a nullipara, diagnosed by MRI, following use of unipolar electrocautery during laparoscopic myomectomy: Case report |
| Q45400945 | Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3). |
| Q42661625 | Vaginal sacrocolporectopexy for the surgical treatment of uterine and vaginal vault prolapses: confirmation of the surgical method and perioperative results of 101 cases |
| Q50226528 | Value and advantages of preoperative sentinel lymph node imaging with SPECT/CT in cervical cancer. |
| Q56342454 | Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility |
| Q83172477 | Variations in the Elasticity of Breast Tissue During the Menstrual Cycle Determined by Real-time Sonoelastography |
| Q84021465 | [Comparison of current methods of prenatal screening for down syndrome] |
| Q82686910 | [HPV-associated anogenital neoplasia in HIV] |
| Q36544653 | c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations |
| Q56334023 | rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology |
Search more.